ClinicalTrials.Veeva

Menu

PBPK Modelling Applied to Acetaminophen Poisoned Obese Children (IntoxPara)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Obesity
Poisoning

Treatments

Other: Anthropomorphism
Other: Relevant clinical datas

Study type

Observational

Funder types

Other

Identifiers

NCT04850014
69HCL20_1244

Details and patient eligibility

About

Childhood obesity is increasing globally. Changes in body composition and physiology in obesity setting modify pharmacokinetic parameters and might increase the risk in case of poisoning. Acetaminophen is a drug often implied in poisoning in children population, especially in adolescent attempting suicide. In practice, clinicians use weight to assess intoxication severity, but depending on the weight chosen (actual weight, lean body weight, ideal weight,..) the severity assessment can change as well as medical care needed. In this context we hypothesize that a PBPK modelling would be helpful to predict toxic dosing in obese population and especially in obese adolescent or children. The primary objective of this study is to collect data related to acetaminophen-poisoned patient with at least one acetaminophen concentration sampling and whose clinical outcome is known in order to refine and validate such a PBPK model.

Enrollment

300 estimated patients

Sex

All

Ages

10+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All subjects >/= 10 year old
  • Availability of at least one positive acetaminophen concentration with its associated sampling time
  • Known clinical outcome

Exclusion criteria

  • < 10 year old
  • lack of data-

Trial design

300 participants in 2 patient groups

Poisoned patients
Description:
All subjects with paracetamolemia in the context of paracetamol poisoning
Treatment:
Other: Anthropomorphism
Other: Relevant clinical datas
Control group
Description:
Acetaminophen-poisoned patient being non-obese
Treatment:
Other: Anthropomorphism
Other: Relevant clinical datas

Trial contacts and locations

1

Loading...

Central trial contact

Kim An NGUYEN, MD; Sébastien RIVAS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems